AMF Tjänstepension’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.6M Sell
928,424
-23,558
-2% -$1.28M 0.23% 72
2026
Q1
$59.7M Sell
951,982
-968
-0.1% -$77.4K 0.4% 56
2025
Q4
$90.9M Buy
952,950
+46,538
+5% +$4.56M 0.56% 40
2025
Q3
$88.5M Buy
906,412
+18,208
+2% +$1.89M 0.56% 36
2025
Q2
$95.4M Buy
+888,204
New +$89.9M 0.63% 35
2024
Q2
Sell
-854,223
Closed -$58.5M 225
2024
Q1
$58.5M Buy
854,223
+18,320
+2% +$1.18M 0.44% 47
2023
Q4
$48.3M Buy
835,903
+18,000
+2% +$961K 0.41% 50
2023
Q3
$43.2M Buy
817,903
+654,093
+399% +$34.3M 0.42% 45
2023
Q2
$8.86M Buy
163,810
+42,700
+35% +$2.23M 0.08% 154
2023
Q1
$6.06M Hold
121,110
0.06% 167
2022
Q4
$5.6M Buy
+121,110
New +$5.24M 0.06% 170

Other funds holding BSX

AMF Tjänstepension's BSX Position: Q2 2026 in Review

AMF Tjänstepension reduced its Boston Scientific (BSX) stake by 2.5% in Q2 2026, selling an estimated $1.28M and leaving 928,424 shares worth $39.6M. The position accounts for 0.23% of the portfolio, ranked #72.

AMF Tjänstepension first reported a position in BSX in Q4 2022 and has held it in 11 quarters since. The position peaked at $95.4M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AMF Tjänstepension held 928,424 shares of Boston Scientific worth $39.6M as of Q2 2026.
  • AMF Tjänstepension sold 23,558 Boston Scientific shares in Q2 2026, an estimated $1.28M.
  • Boston Scientific made up 0.23% of AMF Tjänstepension's portfolio in Q2 2026, its #72 holding.
  • AMF Tjänstepension first reported a position in Boston Scientific in Q4 2022 and has held it in 11 quarters since.
  • AMF Tjänstepension's Boston Scientific position peaked at $95.4M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AMF Tjänstepension's 13F filing for Q2 2026, filed 6 Aug 2026.